The Pancreatic Cancer Action Network is joining leading organizations to offer the following continuing education opportunities for healthcare professionals.
Triage Cancer Conference
October 3, 2020
Virtual Attendance
Triage Cancer offers a series of FREE educational conferences for individuals diagnosed with cancer, caregivers, advocates, and oncology healthcare professionals.* Learn valuable information about navigating practical cancer survivorship issues, from beyond diagnosis, into post-treatment survivorship.
Learn More
Triage Cancer Conference
October 10, 2020
Chicago, IL
Triage Cancer offers a series of FREE educational conferences for individuals diagnosed with cancer, caregivers, advocates, and oncology healthcare professionals.* Learn valuable information about navigating practical cancer survivorship issues, from beyond diagnosis, into post-treatment survivorship.
Learn More
Pancreas Cancer Symposium 2020: Current and Future
November 20, 2020
New York, NY
This one day course in conjunction with the Center for Pancreas Cancer Research (CPCR) at Memorial Sloan Kettering (MSK) will review the epidemiology, genomic, molecular and pathologic underpinnings of pancreas adenocarcinoma along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic stages of the disease. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments and emerging directions.
Learn More
Pancreas Cancer 2021
April 26 – 29, 2021
Erlangen, Germany
This conference will provide a common platform for all specialists involved in pancreatic cancer to interact and share the latest information and developments. This will include promoting the highest standards of treatment, education and training, clinical and basic research, disease prevention, and patient care at a multi-disciplinary level. Pancreas Cancer 2021 will bring together healthcare professionals from all over the globe, to explore current knowledge in the treatment of pancreatic cancer.
Learn More
